China Research Says Anti-Retrovirals Less Effective For HIV Partners
This article was originally published in PharmAsia News
China-based research counters previous reports about HIV drugs, saying they are not nearly as effective in protecting uninfected partners as previous work suggested.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.